Targeting Some Enzymes with Repurposing Approved Pharmaceutical Drugs for Expeditious Antiviral Approaches Against Newer Strains of COVID-19.

Mohanty, Swati Sucharita; Sahoo, Chita Ranjan; Padhy, Rabindra Nath

Mohanty, Swati Sucharita; Sahoo, Chita Ranjan; Padhy, Rabindra Nath.

Afiliação

Mohanty SS; Cytogenetics Laboratory, PG Department of Zoology, Utkal University, Bhubaneswar, Odisha, 751004, India.
Sahoo CR; Central Research Laboratory, IMS & SUM Hospital, Siksha O Anusandhan Deemed to be University, Bhubaneswar, Odisha, 751003, India.
Padhy RN; Central Research Laboratory, IMS & SUM Hospital, Siksha O Anusandhan Deemed to be University, Bhubaneswar, Odisha, 751003, India. rnpadhy54@gmail.com.

AAPS PharmSciTech ; 22(6): 214, 2021 Aug 10.

Article em En | MEDLINE | ID: mdl-34378108

Assuntos

Tratamento Farmacológico da COVID-19; Antivirais/farmacologia; Antivirais/uso terapêutico; Reposicionamento de Medicamentos; Humanos; Preparações Farmacêuticas; RNA Viral; SARS-CoV-2

Palavras-chave

COVID-19; SARS CoV2; positive-sense single-stranded RNA virus; repurposing drugs; target inhibition

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Limite: Humans Idioma: En Revista: AAPS PharmSciTech Assunto da revista: FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google